NCT07400926

Observational Trial of the Updated Inserter for the Travoprost Intracameral Implant 75mcg

Clinical In-use Observational Trial to Evaluate the Updated Inserter for the Travoprost Intracameral Implant 75 mcg

• Status: Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 30 (estimated)
• Sponsor: Glaukos Corporation · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Clinical in-use observational trial to evaluate the updated inserter for the Travoprost Intracameral implant using the updated inserter (Model G2-TRIO)

Detailed description

The objective of this study is to evaluate the administration of the Travoprost intracameral implant using the updated inserter (Model G2-TRIO)

Conditions

• Open Angle Glaucoma (OAG)
• Ocular Hypertension (OH)

Interventions

Type	Name	Description
COMBINATION_PRODUCT	Travoprost	Travoprost intracameral implant, 75mcg administered using the sterile, single-dose updated inserter (Model G2-TRIO)

Timeline

• Start date: 2025-12-17
• Primary completion: 2026-06-01
• Completion: 2026-07-01
• First posted: 2026-02-10
• Last updated: 2026-02-27

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated drug study